OraSure Technologies, Inc.
General ticker "OSUR" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $240.3M (TTM average)
OraSure Technologies, Inc. does not follow the US Stock Market performance with the rate: -1.7%.
Estimated limits based on current volatility of 2.3%: low 2.66$, high 2.78$
Factors to consider:
- Total employees count: 501 (-21.5%) as of 2024
- US accounted for 74.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Genomics market changes, Geopolitical risks, Manufacturing scalability issues, Leadership changes, Customer concentration
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.96$, 3.85$]
- 2025-12-31 to 2026-12-31 estimated range: [1.81$, 3.51$]
Financial Metrics affecting the OSUR estimates:
- Positive: with PPE of 91.6 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: 6.63 < Operating cash flow per share per price, % of 10.04
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: Shareholder equity ratio, % of 85.55 > 64.17
- Positive: -9.48 < Industry operating profit margin (median), % of -6.69
Short-term OSUR quotes
Long-term OSUR plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $387.48MM | $405.47MM | $185.83MM |
| Operating Expenses | $410.44MM | $372.79MM | $214.08MM |
| Operating Income | $-22.96MM | $32.68MM | $-28.25MM |
| Non-Operating Income | $6.48MM | $23.57MM | $12.25MM |
| R&D Expense | $36.24MM | $33.73MM | $26.05MM |
| Income(Loss) | $-16.48MM | $56.26MM | $-16.00MM |
| Taxes | $1.46MM | $2.60MM | $1.80MM |
| Other Income(Loss) | $0.00MM | $0.00MM | $-1.70MM |
| Profit(Loss)* | $-17.13MM | $53.66MM | $-19.50MM |
| Stockholders Equity | $364.43MM | $430.67MM | $410.34MM |
| Inventory | $95.70MM | $47.61MM | $34.20MM |
| Assets | $444.18MM | $482.85MM | $479.66MM |
| Operating Cash Flow | $-47.20MM | $141.58MM | $27.37MM |
| Capital expenditure | $63.91MM | $10.30MM | $3.80MM |
| Investing Cash Flow | $21.09MM | $66.15MM | $-39.03MM |
| Financing Cash Flow | $-3.83MM | $-3.02MM | $-4.18MM |
| Earnings Per Share** | $-0.24 | $0.73 | $-0.26 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.